Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-26-177629
Filing Date
2026-04-24
Accepted
2026-04-24 17:08:07
Documents
1
Effectiveness Date
2026-04-24

Document Format Files

Seq Description Document Type Size
1 S-8 POS d147976ds8pos.htm S-8 POS 22596
  Complete submission text file 0001193125-26-177629.txt   23883
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 239-2030
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-269816 | Film No.: 26895639
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)